Visa Forecast, price target & analysts
Visa Target price 2026 - Analyst rating & recommendation
Visa Classifications & Recommendation
Visa Price Target
| Target Price | $428.40 |
| Price | $391.43 |
| Potential | 9.44% |
| Number of Estimates | 44 |
| 44 Analysts have issued a price target Visa 2027 . The average Visa target price is $428.40. This is 9.44% higher than the current stock price. The highest price target is $489.30 25.00% , the lowest is $339.97 13.15% . | |
| A rating was issued by 51 analysts: 45 Analysts recommend Visa to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Visa stock has an average upside potential 2027 of 9.44% . Most analysts recommend the Visa stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2030
44 Analysts have issued a sales forecast Visa 2026 . The average Visa sales estimate is
This results in the following potential growth metrics:
31 Analysts have issued an Visa EBITDA forecast 2026. The average Visa EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
45 Visa Analysts have issued a net profit forecast 2026. The average Visa net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
45 Analysts have issued a Visa forecast for earnings per share. The average Visa EPS is
This results in the following potential growth metrics and future valuations:
Current Visa Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Baird |
Outperform
➜
Outperform
|
Unchanged | Oct 12 2026 |
| RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Aug 31 2026 |
| Wolfe Research |
Outperform
➜
Outperform
|
Unchanged | Aug 25 2026 |
| Truist Securities |
Buy
➜
Buy
|
Unchanged | Aug 05 2026 |
| Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Aug 03 2026 |
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Jul 30 2026 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Jul 29 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Baird:
Outperform
➜
Outperform
|
Oct 12 2026 |
|
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Aug 31 2026 |
|
Unchanged
Wolfe Research:
Outperform
➜
Outperform
|
Aug 25 2026 |
|
Unchanged
Truist Securities:
Buy
➜
Buy
|
Aug 05 2026 |
|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Aug 03 2026 |
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Jul 30 2026 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Jul 29 2026 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
